METTL3-mediated m6A modification of DNMT1 enhances ovarian cancer progression
Kanchan Kumari, Iván Pérez-Núñez, Aleix Noguera‐Castells, Raquel Pluvinet, Carlos Peula, Annika Patthey, Ghazala Naz Khan, Kinga Pajdzik, Ángel Román, Erik Dassi, Chuan He, Eva Lundin, Manel Esteller, Toni Celià-Terrassa, Francesca Aguiló
This study identifies METTL3-mediated m6A modification of DNMT1 as a driver of ovarian cancer progression by enhancing DNMT1 translation and suppressing tumor suppressors.
bioRxiv · Sep 10, 2025 · PreprintCancer Biology